Table 2. Baseline Patient Characteristics.
VARIABLE | NOT TRANSFUSED(N = 25,662) | TRANSFUSED(N = 1,929) | UNADJUSTEDP VALUE |
Age at diagnosis (mean years) | 63.3 | 63.4 | 0.74 |
Gender(% Female) | 52.3% | 46.7% | <0.0001 |
Type of Cancer: n (%) | |||
Gastrointestinal | 4,323 (16.9%) | 477 (24.7%) | <0.0001 |
Breast | 5,141 (20.0%) | 119 (6.2%) | |
Genitourinary | 4,246 (16.6%) | 166 (8.6%) | |
Lung | 3,419 (13.3%) | 455 (23.6%) | |
Hematologic | 1,347 (5.3%) | 183 (9.5%) | |
Other | 7,186 (28.0%) | 529 (27.4%) | |
Stage: n (%) | |||
0 | 646 (2.5%) | 6 (0.3%) | <0.0001 |
I | 3,813 (14.9%) | 100 (5.2%) | |
II | 4,612 (18.0%) | 203 (10.5%) | |
III | 2,538 (9.9%) | 321 (16.6%) | |
IV | 2,583 (9.9%) | 570 (29.5%) | |
Unknown | 11470 (44.7%) | 729 (37.8%) | |
Treatment: n (%) | |||
Chemotherapy | 12,088 (47.1%) | 1,248 (64.7%) | 0.045 |
Radiation | 14,250 (55.5%) | 1,249 (64.7%) | 0.078 |
Surgery | 14,666 (57.2%) | 763 (39.6%) | 0.59 |
Cancer Recurrence: n (%) | |||
8,533 (33.3%) | 1,092 (56.6%) | <0.0001 |